RSSL | 106.45% | 87.81 | +0.91% | 15,706,957 | |
Cincor Pharma Inc - Cvr | - | 0.00% | - | - | 15,984 |
Warrant on Inhibrx Inc Ordinary Shares | - | 0.00% | - | - | 15,798 |
Warrant on Novartis AG Registered Shares | - | 0.00% | - | - | 26,043 |
Pulse Biosciences ([Wts/Rts]) 0% | - | 0.00% | - | - | 1,148 |
Cartesian Therapeutics ([Wts/Rts]) 0% | - | 0.00% | - | - | 1 |
Omniab | - | 0.00% | - | - | 2,421 |
Omniab | - | 0.00% | - | - | 2,421 |
Global X Funds - Global X Russell 2000 Covered Call ETF is an exchange traded fund launched and managed by Global X Management Company LLC. The fund invests in public equity markets of the United States. The fund invests directly and through derivatives in stocks of companies operating across diversified sectors. It uses derivatives such as options to create its portfolio. It invests in growth and value stocks of small-cap companies. The fund seeks to track the performance of the Cboe Russell 2000 BuyWrite Index, by using representative sampling technique. Global X Funds - Global X Russell 2000 Covered Call ETF was formed on April 17, 2019 and is domiciled in the United States.